Principal investigator Elizaveta Kon, MD, PhD, of Humanitas Orthopedic Center of Milan, Italy, enrolled the 100th patient in CariHeal's Agili-C Investigational Device Exemption pivotal study.
Here are five insights:
1. The newest patient suffers from an osteochondral defect in the center of the trochlea.
2. Dr. Kon said the patient was randomized into the Agili-C arm of the study and treated with a single implant.
3. This is Dr. Kon's eighth patient in the study. She plans to enroll more in the future.
4. Agili-C has been implanted in more than 400 patients with cartilage lesions in the knee, ankle and big toe throughout centers in Europe and Israel.
5. The implant is designed to treat a broad spectrum of cartilage lesions, from single focal lesions and multiple and large defects in patients suffering from osteoarthritis.